Abbott (NYSE: ABT) announced today that it launched a next-generation delivery system for its neuromodulation business.
Abbott has launched a “next-generation” delivery system to streamline the electrode implantation process for its Proclaim DRG neurostimulation system. This advancement aims to improve treatments for ...
Background In spite of recent advances in post-operative pain relief, pain following orthopedic surgery remains an ongoing challenge for clinicians. We examined whether a well known and frequently ...
like pain relief, ability to perform daily activities and sleep quality, throughout each stage of the treatment, said Abbott. It allows users to measure and document their pain through a series of ...